RespiVent Dosepack DF

RespiVent Dosepack DF Uses, Dosage, Side Effects, Food Interaction and all others data.

RespiVent Dosepack DF
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	RespiVent Dosepack DF
Generic	Chlorpheniramine maleate + methscopolamine nitrate
Type	Tablets
Therapeutic Class
Manufacturer
Available Country	United States
Last Updated:	September 19, 2023 at 7:00 am

Uses

Chlorpheniramine Maleate is indicated in the following indications- Urticaria Sensitivity reactions Angioneurotic edema Vasomotor rhinitis Cough Common cold Motion sickness and Other allergic conditions.

Dosage

RespiVent Dosepack DF dosage

Adult- Usual adult dose is 4 mg every 4-6 hours, maximum 24 mg daily. Child- 6-12 years: 2 mg every 4-6 hours, maximum 12 mg daily. 2-5 years: 1 mg every 4-6 hours, maximum 6 mg daily. 1-2 years: 1 mg twice daily. Below 1 year the use of Chlorpheniramine Maleate is not recommended.

Side Effects

Chlorpheniramine is well-tolerated, but sometimes drowsiness, dizziness, muscular weakness, and gastrointestinal upset may occur.

Precaution

Chlorpheniramine should be used with caution in patients with glaucoma and prostatic hypertrophy. During therapy with chlorpheniramine, caution should be taken in driving vehicles and operating machinery.

Interaction

Chlorphenamine maleate has been reported to be incompatible with calcium chloride, kanamycin sulfate, noradrenaline acid tartrate, pentobarbital sodium, and meglumine adipiodone.

Pregnancy & Breastfeeding use

This drug should not be used in lactating mother and in pregnancy especially during the first trimester of pregnancy.

Contraindication

Chlorpheniramine is contraindicated in patients hypersensitive to this agent, in newborn or premature infants.

Acute Overdose

CNS depression (including sedation, apnea, CV collapse), CNS stimulation (including insomnia, hallucination, tremors, convulsions), tinnitus, blurred vision, dizziness, ataxia, hypotension. Stimulation and atropine-like signs and symptoms (including dry mouth, fixed dilated pupils, flushing, hyperthermia, Gl symptoms) are more likely in children.